Associated Papers
Functional characteristics and therapeutic potential of SLC41 transporters.
Nemoto T et al.
Journal of Pharmacological Sciences, 2023
Alzheimer's Disease-Associated SNP rs708727 in SLC41A1 May Increase Risk for Parkinson's Disease: Report from Enlarged Slovak Study.
Cibulka M et al.
International Journal of Molecular Sciences, 2022
SNPs rs11240569, rs708727, and rs823156 in SLC41A1 Do Not Discriminate Between Slovak Patients with Idiopathic Parkinson's Disease and Healthy Controls: Statistics and Machine-Learning Evidence.
Cibulka M et al.
International Journal of Molecular Sciences, 2019
SLC41A1 and TRPM7 in magnesium homeostasis and genetic risk for Parkinson's disease.
Sturgeon M et al.
Journal of Neurology & Neuromedicine, 2016
Genetic analysis of SLC41A1 in Chinese Parkinson's disease patients.
Wang L et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics, 2015
Variant R244H in Na+/Mg2+ exchanger SLC41A1 in Taiwanese Parkinson's disease is associated with loss of Mg2+ efflux function.
Lin CH et al.
Parkinsonism & Related Disorders, 2014
Select a paper to view details